(Q46525474)

English

Pharmacokinetics of gemcitabine combined with trastuzumab in patients with advanced breast cancer

scientific article published on 2 June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Pharmacokinetics of gemcitabine combined with trastuzumab in patients with advanced breast cancer (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

1 reference

based on heuristic

inferred from title

author name string

Martin Czejka

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Eva Ostermann

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Leila Muric

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Doris Heinz

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Johannes Schueller

5

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

publication date

2 June 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

28

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

318-322

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

6-7

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Gemcitabine and small cell lung cancer

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

New combinations with Herceptin in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

Gemcitabine and trastuzumab in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

Increased intracellular doxorubicin by anti-FAS monoclonal antibody: a mechanism that enhances the cytotoxicity in renal cell carcinoma cells

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

Influence of trastuzumab on epirubicin pharmacokinetics in metastatic breast cancer patients

1 reference

https://api.crossref.org/works/10.1159%2F000085596

21 January 2018

Identifiers

10.1159/000085596

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15933419

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46525474&oldid=2116192478"